Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Prostaglandins Other Lipid Mediat. 2014 Aug 22;0:45–51. doi: 10.1016/j.prostaglandins.2014.08.002

Table 2.

Associations between eicosanoid/urine creatinine and eGFR or Urine Protein

eGFR Proteinuria

Unadj Fully Adj* Unadj Fully Adj*
20-HETE 19.44 p=0.001 (8.26, 30.62) 17.47 p=0.001 (7.37, 27.57) 1.23 p=0.307 (0.83, 1.83) 1.39 p=0.175 (0.86, 2.25)
R2 0.05 R2 0.31 - -
19-HETE 12.56 p=0.028 (1.37, 23.75) 60.68 p=0.005 (18.48, 102.88) 0.98 p=0.960 (0.43, 2.21) 22.12 p=0.003 (2.80, 175.05)
R2 0.02 R2 0.31 - -
15-HETE 23.12 p=0.060 (−0.99, 47.22) 7.97 p=0.710 (−34.34, 50.28) 0.39 p=0.009 (0.19, 0.79) 0.09 p=0.016 (0.01, 0.63)
R2 0.02 R2 0.24 - -
12-HETE 3.40 p=0.141 (−1.14, 7.94) −5.07 p=0.195 (−12.78, 2.63) 0.95 p=0.572 (0.78, 1.14) 1.06 p=0.720 (0.77, 1.45)
R2 0.01 R2 0.27 - -
8-HETE 119.01 p<0.001 (57.03, 180.99) 378.89 p=0.001 (160.01, 597.77) 0.06 p=0.001 (0.01, 0.33) 0.09 p=0.623 (0.00, 1293.61)
R2 0.08 R2 0.31 - -
14,15-diHETE 9.00 p=0.002 (3.24, 14.77) 9.83 p=0.062 (−0.50, 20.17) 0.81 p=0.029 (0.67, 0.98) 0.85 p=0.617 (0.45, 1.62)
R2 0.04 R2 0.28 - -
11,12-diHETE 49.28 p<0.001 (22.27, 76.28) 183.83 p<0.001 (87.50, 280.16) 0.34 p=0.003 (0.17, 0.70) 0.03 p=0.152 (0.00, 3.62)
R2 0.07 R2 0.32 - -
8,9-diHETE 6.01 p<0.001 (3.96, 8.06) 8.33 p<0.001 (5.56, 11.10) 0.90 p<0.001 (0.85, 0.95) 0.94 p=0.378 (0.81, 1.08)
R2 0.13 R2 0.40 - -
5,6-diHETE 39.09 p<0.001 (22.08, 56.10) 112.04 p<0.001 (74.27, 149.81) 0.46 p<0.001 (0.31, 0.70) 0.30 p=0.163 (0.05, 1.64)
R2 0.09 R2 0.39 - -

For eGFR outcomes, beta coefficients (slope) with p-values, 95% confidence intervals, and r values are shown. For proteinuria outcomes, incidence rate ratios (IRR) are reported with p-values and 95% confidence intervals. Unadjusted and fully adjusted models are shown, with fully adjusted models having age, gender, BMI, systolic blood pressure, diastolic blood pressure, diabetes, lupus, and medications from table 3 used as confounders.